Since angiogenesis is mainly induced by phosphorylation of VEGFR2, it is pivotal to inhibit the activation of the VEGFR2 signaling, which can stimulate downstream molecules, such as Akt and ERK, when treating a malignant tumor [28]. This evidence concerns the gene AKT1 and cancer.